ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Keywords Studios Plc

Keywords Studios Plc (KWS)

1,158.00
22.00
( 1.94% )
Updated: 06:52:57

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1,158.00
Bid
1,158.00
Ask
1,163.00
Volume
32,579
1,131.00 Day's Range 1,162.00
1,101.00 52 Week Range 2,718.00
Market Cap
Previous Close
1,136.00
Open
1,131.00
Last Trade
94
@
1158
(AT)
Last Trade Time
06:51:09
Financial Volume
375,301p
VWAP
1,151.9736
Average Volume (3m)
433,091
Shares Outstanding
78,816,970
Dividend Yield
0.23%
PE Ratio
45.59
Earnings Per Share (EPS)
0.25
Revenue
780.45M
Net Profit
19.95M

About Keywords Studios Plc

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
London, Gbr
Founded
1970
Keywords Studios Plc is listed in the Business Services sector of the London Stock Exchange with ticker KWS. The last closing price for Keywords Studios was 1,136p. Over the last year, Keywords Studios shares have traded in a share price range of 1,101.00p to 2,718.00p.

Keywords Studios currently has 78,816,970 shares outstanding. The market capitalization of Keywords Studios is £909.55 million. Keywords Studios has a price to earnings ratio (PE ratio) of 45.59.

KWS Latest News

Keywords Studios PLC Publication of Annual Report and Accounts

Keywords Studios PLC 19 April 2024   19 April 2024    Keywords Studios plc ("Keywords Studios", the "Group") Publication of Annual Report and Accounts Keywords Studios, the global provider of...

Keywords Studios PLC Issue of Shares

Keywords Studios PLC 10 April 2024    10 April 2024    Keywords Studios plc ("Keywords Studios", the "Company")  Issue of Shares Keywords Studios, the international provider of creative and...

Keywords Studios PLC Total Voting Rights

Keywords Studios PLC 02 April 2024   2 April 2024    Keywords Studios plc ("the Company")   Total Voting Rights   In accordance with DTR 5.6 of the Financial Conduct Authority's Disclosure...

Keywords Studios PLC Holding(s) in Company

Keywords Studios PLC 22 March 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BBQ38507 Issuer Name KEYWORDS STUDIOS PLC UK or Non-UK Issuer UK 2...

Keywords Studios PLC Issue of Shares

Keywords Studios PLC 14 March 2024    14 March 2024    Keywords Studios plc ("Keywords Studios", the "Company")  Issue of Shares Keywords Studios, the international provider of creative and...

Keywords revenue rises despite "difficult" 2023 for video game sector

Keywords Studios PLC on Wednesday set out an optimistic outlook and lifted its dividend as it hailed a "resilient" 20 ...

Keywords Studios PLC Final Results

Keywords Studios PLC 13 March 2024                                                                                                                                                               ...

Keywords Studios PLC Director/PDMR Shareholding

Keywords Studios PLC 06 March 2024   6 March 2024    Keywords Studios plc ("Keywords Studios", "the Company")   NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-22-1.864406779661180120811151984841158.06708551DE
4-132-10.23255813951290131311013614881183.32771693DE
12-511-30.61713600961669179111014330911374.79654716DE
26-142-10.92307692311300179111013315111403.86166642DE
52-1520-56.75877520542678271811013340451592.86823062DE
156-1742-60.06896551722900336611012355352133.49690511DE
260-392-25.29032258061550336610692818291938.2748874DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.41
(65.88%)
1.35M
PEGYPineapple Energy Inc
$ 0.072
(38.73%)
18.63M
BCSAUBlockchain Coinvestors Acquisition Corporation I
$ 15.11
(34.31%)
138.28k
FRGTFreight Technologies Inc
$ 1.20
(31.33%)
3.9M
BIAFbioAffinity Technologies Inc
$ 3.16
(31.12%)
1
ZENVZenvia Inc
$ 1.67
(-24.09%)
5
AHGAkso Health Group
$ 0.60
(-22.08%)
10
ACONAclarion Inc
$ 0.3123
(-20.47%)
212.43k
ANLAdlai Nortye Ltd
$ 10.80
(-19.76%)
2
NSYSNortech Systems Inc
$ 14.00
(-19.08%)
2
PEGYPineapple Energy Inc
$ 0.072
(38.73%)
18.63M
FRGTFreight Technologies Inc
$ 1.20
(31.33%)
3.9M
KTRAKintara Therapeutics Inc
$ 0.19
(20.25%)
3.13M
TVGNTevogen Bio Holdings Inc
$ 1.41
(65.88%)
1.35M
SQQQProShares UltraPro Short QQQ
$ 11.645
(-2.96%)
1.27M

Discussion

View Full Feed
Mojocash Mojocash 4 minutes ago
Is that the cut off? 100 million and above?
DJT
Mark Mark 5 minutes ago
$PEGY looking good in pm, .08 test here
PEGY
Thomas@yahoo Thomas@yahoo 5 minutes ago
https://www.sciencedirect.com/science/article/abs/pii/S0278584624000824
CVSI
Poundthetable Poundthetable 6 minutes ago
Just lost patience I wish the company would of followed through with more updates feels like they are leaving us hanging and letting us sink into the abyss
Especially if a merger was coming you think the chart would get more interesting as well but I don’t see the momo as of yet
I wis
TDRK
Chiron Chiron 6 minutes ago
50 cents next month? Higher?
IGPK
Mark Mark 7 minutes ago
$FRGT 1.20 nice gapper
FRGT
Bubae Bubae 7 minutes ago
You should learn the terms "facts","links" and "conjecture".
BEGI
Raider21 Raider21 7 minutes ago
Quote: I’m looking forward to what Sfrx finds! I’m sure a few folks have no idea how the Sea Searcher works! 3D imaging by SFRX’S equipment they created!!
_________________________________________________________

Under water 3D imaging (sub-bottom profiling) has been around for
SFRX
willpellel willpellel 8 minutes ago
So noble
PSRU
hopester hopester 9 minutes ago
Meta has nothing in common with FCEL. In the last 3yrs Meta ran from $100/sh to over $500/sh. In the same period FCEL went from just under $12/sh to $.86.
And FCEL's performance came when the whole market moved to new historic highs. Does that tell you something about "numbers". The perform
FCEL
Zadie420 Zadie420 9 minutes ago
Really. "I wouldn’t assume “franchise” is some sort of bread crumb"

I am sure a company with financial resources available has gone thru extensive research to find the best way to market their platform. I am sure they have most experience in this field than unknown poster in IHUB. Goo
NWBO
the submariner the submariner 10 minutes ago
Looking good!!!!
https://youtu.be/8wOHyVEyq2Y?si=jdpWtF_rW5L-T6Cq
VIZC
Thomas@yahoo Thomas@yahoo 10 minutes ago
https://www.nature.com/articles/s41432-024-01007-5
CVSI
JOoa0ky JOoa0ky 11 minutes ago
Commons to the MOON $444/SHARE 🚀🚀🚀
FNMA
TOM611 TOM611 11 minutes ago
Night I like how you think
XALL
edbi46 edbi46 11 minutes ago
NOPAIN Act

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—
Notwithstanding an
SAI WBA
TOM611 TOM611 11 minutes ago
#8 B O B. We A. I. gotta lotta eyes.
XALL
Raider21 Raider21 13 minutes ago
Quote: There are a minimum of 3 misstatements in this post. Now that is a real fact you could take to the bank.
___________________________________________

Why don't you tell me specifically what they are so I can take them to the bank, as you say.
SFRX
jjtcwine jjtcwine 14 minutes ago
G.M,, BCSAU 11 to $50 bask to 15ish
cableguy cableguy 14 minutes ago
EXACTLY.... SPZI TO THE MOON, in due time...
SPZI
infamous infamous 14 minutes ago
NGMS ticker no longer exists
EBET
PJ007 PJ007 14 minutes ago
it's there Pete:

[0632] In some embodiments, the additional therapeutic agent is viral entry inhibitor, such as brilacidin.
IPIX
Tom turtles Tom turtles 15 minutes ago
"Company expects to file on or before the 15th of the month"..So , they are just outright friggen liars ,correct ? Would you expect anything else from this scumbag ?
RNVA
Frankestin Frankestin 16 minutes ago
https://ir.apollomicsinc.com/news-releases/news-release-details/apollomics-announces-approval-vebreltinib-china-first-class
Important!
Whoever be short here deserves to know about this disease!
APLM
cableguy cableguy 16 minutes ago
Yes absolutely did for me, and not a one of the indicators or overlays you used was on my charts. Keep drinking the FOOL AID
it serves you well. Oh no I didn't sell either because of one little FACT... But I won't tell you why.
SPZI

Your Recent History

Delayed Upgrade Clock